Decision to fully return retirement benefit trust; return date is September 28, 2026; expected return amount about 26.1 billion yen. In the standalone financial statements, retirement benefit trust return income of about 17.3 billion yen is planned to be recognized as a special profit (there is no impact on the consolidated IFRS-compliant figures).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4506","jir_company_name":"Sumitomo Pharma Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4506-20260828-01.pdf","jir_short_summary":"Decision to fully return retirement benefit trust; return date is September 28, 2026; expected return amount about 26.1 billion yen. In the standalone financial statements, retirement benefit trust return income of about 17.3 billion yen is planned to be recognized as a special profit (there is no impact on the consolidated IFRS-compliant figures).","jir_summary":"### Section heading\nThis release is an announcement regarding the full return of the retirement benefit trust and the recognition of related special profit. Since future benefit assets are expected to remain in excess, we have decided to return the retirement benefit trust and plan to recognize retirement benefit trust return income of about 17.3 billion yen as a special profit in the standalone financial statements (Japanese standards) for the fiscal year ending March 2027. There is no impact on the consolidated financial statements as they are IFRS-compliant.\n\n### Section 2 heading\nWith the return, we expect to amortize unrecognized actuarial differences in one lump sum, and the actual amount will be finalized at the time of return. Specific figures may be finalized at the time of future disclosure.","jir_financial_highlights":"Expected retirement benefit trust return: approx. 261 hundred million yen (Unknown)\nRetirement benefit trust return income: approx. 173 hundred million yen (Unknown)\nScheduled return date: September 28, 2026 (Unknown)","jir_category":"","jir_hashtags":"#SubjectNotRelatedToOwnShares, #FinancialInformation","jir_key_figures":"Retirement benefit trust return expected amount: approx. 261 hundred million yen\nRetirement benefit trust return income: approx. 173 hundred million yen\nScheduled return date: September 28, 2026","jir_meta_title":"Sumitomo Pharma: Notice of retirement benefit trust return income recognition | August 2026","jir_meta_description":"Sumitomo Pharma has decided to return the entire retirement benefit trust. The expected return amount is about 26.1 billion yen, with about 17.3 billion yen to be recognized as special profit. No impact on consolidated IFRS figures. Return date: September 28, 2026.","jir_og_title":"Sumitomo Pharma | Notice of retirement benefit trust return income recognition","jir_og_description":"About the retirement benefit trust return and the recognition of special profit. Return amount about 26.1 billion yen, special profit about 17.3 billion yen, no impact on consolidated figures.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7612,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-108333","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n